Safety and Effects on Responses to Stress and Pain of Natural Medical Marijuana Products

Completed · Phase 1 · Has a placebo group

Conditions studied: Pain

In brief

This proposal aims to systematically examine the safety and pharmacokinetic/pharmacodynamic profile and the physiologic, neuroendocrine and behavioral stress and pain responses to acute single doses and repeated dosing of oral tablet formulation of natural Cannabidiol (CBD) alone and in combination with Tetrahydrocannabinol and matched Placebo (PLA).

Key facts

Study ID
NCT04226690
Run by
Yale University
People needed
24
Starts
2022-11-15
Expected to finish
2023-12-15
Last updated by the study team
2024-07-19

Who can join

Age: 21 and older, up to 68. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.